Support
DONATE
DONATE
National Cancer Plan England 2025 – Consultation Open  

National Cancer Plan England 2025 – Consultation Open  

by | Feb 18, 2025

National Cancer Plan England 2025 – Consultation Open   Last year, Lord Darzi’s independent investigation into the NHS, found the need to improve cancer diagnosis rates, waits and outcomes.   To mark World Cancer Day, on Tuesday 4th February 2025, the Secretary of...
NHS Genomics Strategy

NHS Genomics Strategy

by | Oct 12, 2022

NHS Genomics Strategy launched today at #NHSGenomics2022 by @AmandaPritchard It sets out our ambitions over the next 5-10 years to harness the potential of genomics to transform patient care. https://www.england.nhs.uk/genomics/genomics-strategy/
NHS Cancer Quality of Life Survey Launch

NHS Cancer Quality of Life Survey Launch

by | Oct 26, 2021

Monday 25th October saw the launch of the NHS Cancer Quality of Life Survey data dashboard. The survey is for people in England who have been diagnosed with cancer. From 2020, people who have had a breast, prostate or colorectal (bowel) cancer diagnosis are being...
100,000 Genomes Project

100,000 Genomes Project

by | Apr 21, 2021

Genomics : PART ONE : 100,000 Genomes Project – and beyond! In late 2012, the then Prime Minister, David Cameron, announced the 100,000 Genomes Project.  Its four main aims were;  to enable new scientific discovery and medical insights to bring benefit to...
NICE approves Avelumab

NICE approves Avelumab

by | Apr 21, 2021

21st APRIL NICE APPROVES AVELUMAB Neuroendocrine Cancer UK is delighted to share with you NICE’s approval of Avelumab as a first line therapy option in metastatic MCC.  Avelumab is now recommended as an option for treating metastatic Merkel cell carcinoma in adults...